Literature DB >> 9598926

Production of cytokines in patients infected by hepatitis C virus.

B Cribier1, C Schmitt, D Rey, J M Lang, A Kirn, F Stoll-Keller.   

Abstract

T helper type 1 (Th1) cytokines play an important role in antiviral defence. The purpose of this study was to quantify by ELISA IL2, soluble receptor of IL2 (IL2Rs), IFNgamma TNFbeta, IL4, IL6 and IL10 levels in the sera of 134 HCV-positive patients, 69 of whom were coinfected with HIV, and in 54 HIV-HCV-negative patients. The mean IL2Rs and IFN serum levels were much higher in patients with anti-HCV than in the control group, whereas the mean IL4 and IL6 levels were lower in patients infected with HCV. There were no significant differences in cytokine levels between patients with and without HIV. There were significantly less patients with HCV than controls with IFNgamma levels under cut-off, and significantly more patients with HCV with IL4 levels under cut-off. Although serum level of cytokines must be interpreted with caution, the results suggest that Th1 response is enhanced in HCV infection.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9598926     DOI: 10.1002/(sici)1096-9071(199806)55:2<89::aid-jmv1>3.0.co;2-j

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  11 in total

1.  Expression of regeneration and tolerance factor correlates directly with human immunodeficiency virus infection and inversely with hepatitis C virus infection.

Authors:  C C Sung; J S Boomer; T S Givens; B K DuChateau; M R Lepe; A Feller; M P Westerman; A Gilman-Sachs; A Chedid; K D Beaman
Journal:  Clin Diagn Lab Immunol       Date:  2000-03

2.  Early IL-10 predominant responses are associated with progression to chronic hepatitis C virus infection in injecting drug users.

Authors:  J K Flynn; G J Dore; M Hellard; B Yeung; W D Rawlinson; P A White; J M Kaldor; A R Lloyd; R A Ffrench
Journal:  J Viral Hepat       Date:  2010-07-05       Impact factor: 3.728

3.  Lack of evidence for the Th2 predominance in patients with chronic hepatitis C.

Authors:  A Bergamini; F Bolacchi; G Cerasari; C Carvelli; E Faggioli; M Cepparulo; F Demin; I Uccella; B Bongiovanni; P Niutta; M Capozzi; M Lupi; E Piscitelli; G Rocchi; M Angelico
Journal:  Clin Exp Immunol       Date:  2001-03       Impact factor: 4.330

4.  Effect of cytokine gene polymorphism on histological activity index, viral load and response to treatment in patients with chronic hepatitis C genotype 3.

Authors:  Zaigham Abbas; Tariq Moatter; Akber Hussainy; Wasim Jafri
Journal:  World J Gastroenterol       Date:  2005-11-14       Impact factor: 5.742

5.  Cytokine serum levels in patients with chronic HCV infection.

Authors:  Nick E Spanakis; George A Garinis; Evangelos C Alexopoulos; George P Patrinos; Panayotis G Menounos; Alexandra Sklavounou; Evangelos N Manolis; Vassilis G Gorgoulis; Dimitrios Valis
Journal:  J Clin Lab Anal       Date:  2002       Impact factor: 2.352

6.  Polymorphisms of some cytokines and chronic hepatitis B and C virus infection.

Authors:  Qiu-Ju Gao; Dian-Wu Liu; Shi-Yong Zhang; Min Jia; Li-Min Wang; Li-Hong Wu; Shu-Yun Wang; Li-Xin Tong
Journal:  World J Gastroenterol       Date:  2009-11-28       Impact factor: 5.742

Review 7.  Fibromyalgia, hepatitis C infection, and the cytokine connection.

Authors:  Mollie E Thompson; André Barkhuizen
Journal:  Curr Pain Headache Rep       Date:  2003-10

8.  Viral and host factors induce macrophage activation and loss of toll-like receptor tolerance in chronic HCV infection.

Authors:  Angela Dolganiuc; Oxana Norkina; Karen Kodys; Donna Catalano; Gennadiy Bakis; Christopher Marshall; Pranoti Mandrekar; Gyongyi Szabo
Journal:  Gastroenterology       Date:  2007-08-02       Impact factor: 22.682

9.  Serum profile of T helper 1 and T helper 2 cytokines in hepatitis C virus infected patients.

Authors:  Masoomeh Sofian; Arezoo Aghakhani; Ali Asghar Farazi; Mohammad Banifazl; Ali Eslamifar; Niloofar Rashidi; Akbar Khadem Sadegh; Amitis Ramezani
Journal:  Hepat Mon       Date:  2012-12-29       Impact factor: 0.660

10.  Human immunodeficiency virus, hepatitis C, and inflammatory biomarkers in individuals with alcohol problems: a cross-sectional study.

Authors:  Kaku A Armah; Emily K Quinn; Debbie M Cheng; Russell P Tracy; Jason V Baker; Jeffrey H Samet; Matthew S Freiberg
Journal:  BMC Infect Dis       Date:  2013-08-29       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.